NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Finnrick
Free Test
← Tesamorelin vendors

Tianjin Eleli Technology DevelopmentTesamorelin

4 testslatest 15 Jul 2026$1.81/mg median
Message on WhatsApp+85297215245Intelligence report21 pages · who runs this vendorMonitor this vendor24/7 safety alerts · Finnrick Gold
Free peptide testing

Ordered Tesamorelin from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply
+4 more ↓
46%
Finnrick rating
#43 of 82 Tesamorelin vendors
2 of 4 classifiable tests passed
natural 50% · customers 4.7★ (3)
methodology · Purity focus
Finnrick analysis · Tesamorelin

Tianjin Eleli Technology Development's purity-focus record is strongest in its broader Retatrutide set, where most vials clear purity and fill despite two 0% purity/0 mg identity failures. GHK-Cu and Tirzepatide are weaker and more dispersed, with recent fill volatility in GHK-Cu and repeated purity plus identity/quantity misses in Tirzepatide.

methodology →
vendor intelligence report
Vendor Intelligence Report: Tianjin Eleli Technology Development

Source code, product-origin fields and a hidden mail target point beyond the Tianjin storefront to a second operator. The report traces the claimed address, young domain, offshore contact rails, dead Discord invites and unsupported FDA/warehouse claims.

21 pages8 risk factors assessed3 Jul 2026
read the report
Peptides
12 rated · tap to focus
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.87
76%
15
2
GHK-Cu
$0.07
72%
6
3
Tirzepatide
$0.38
66%
5
4
BPC-157
$0.76
54%
4
5
Tesamorelinselected
$1.81
46%
4
6
TB-500
$3.00
34%
1
7
Cagrilintide
$2.30
-
0
8
GLOW
-
-
0
9
Ipamorelin
$1.24
-
0
10
Melanotan II
$0.45
-
0
11
NAD+
$0.01
-
0
12
PT-141
$0.56
-
0
Contact channels
9 channels on file
WhatsApp+85297215245WhatsApp+85244605704WhatsApp+85244616473WhatsApp+85269003235WhatsApp+8613996213753WhatsApp+8615869024012WhatsApp+8615026552709Websiteailailicn.comEmailailaili20120912@gmail.com
Rating trend
Tesamorelin from this vendor, after each test
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%8 Feb 2026: 35%18 Mar 2026: 48%28 Apr 2026: 47%15 Jul 2026: 46%15 Sept 2026: current 46%35%47%46%Feb 26Sep 26
Showing Tesamorelin tests only
Tianjin Eleli Technology Development Tesamorelin test history
4 tests · 2 pass · 2 fail
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
15 Jul 2026Fail
42jwgvt
Tested
lab nameView COA
28 Apr 2026Fail
64k6xu8
Tested
lab nameView COA
18 Mar 2026Pass
w9hjukx
Tested
lab nameView COA
8 Feb 2026Pass
bcv3mfq
Tested
lab nameView COA

About Tianjin Eleli Technology Development test results from Finnrick

Tianjin Eleli Technology Development is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 35 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Tianjin Eleli Technology Development peptides in this dataset are BPC-157 (4 tests), GHK-Cu (6 tests) and Retatrutide (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 35 recent tests.

Corrections
0 corrections
No corrections.
Free peptide testing

Ordered Tesamorelin from Tianjin Eleli Technology Development? Mail in a sample (US only) and let us test it for free.

Test my supply